DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO. Stock

Certificat

DE000ME7KP20

Real-time Bid/Ask 10:31:36 2024-06-05 am EDT
203.3 EUR / 203.38 EUR -0.35% Intraday chart for DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO.
Current month+1.50%
1 month+0.36%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-05 203.6 -0.21%
24-06-04 204.1 +0.38%
24-06-03 203.3 +1.11%
24-05-31 201 +0.53%
24-05-30 200 +0.13%

Delayed Quote Börse Stuttgart

Last update June 05, 2024 at 10:19 am EDT

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN ME7KP2
ISINDE000ME7KP20
Date issued 2024-01-25
Maturity 2024-09-20 (107 Days)
Parity 1 : 1
Emission price 200.3
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 205.3
Lowest since issue 194.6
Spread 0.08
Spread %0.04%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
238.5 USD
Average target price
278.7 USD
Spread / Average Target
+16.85%
Consensus